Gates grants

Billionaire's cash challenge intended to provoke new ideas for improving global health.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Microsoft founder Bill Gates Sunday announced a plan that he hopes will help inspire cures for diseases that kill millions in poor nations. The software mogul told an audience at the World Economic Forum in Davos, Switzerland that his charitable foundation will donate $200 million to help identify and solve "grand challenges in global health" which the private sector has little financial incentive to tackle.

Gates has chosen an international panel of high-profile scientists to draft a list of 10 critical problems whose solution could lead to important healthcare advances for the developing world, such as novel ways to prevent and treat AIDS, developing malaria-resistant mosquitoes, or identifying new vehicles for delivery of micronutrients. The panel is expected to put out their top-10 list sometime this summer along with an invitation to research teams to submit proposals for grants of up to $20 million each.

"While individual submissions will be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Diane Martindale

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours